Buy or sell SQZ Biotech stock pre IPO via an EquityZen fund
SQZ Biotech Stock
SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies.
About SQZ Biotech Stock
SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.
Director of Strategic Scientific Partnerships
Chief Scientific Officer